Wikidata:Database reports/Constraint violations/P5642
Jump to navigation
Jump to search
Constraint violations report for risk factor (Discussion, uses, items, changes, related properties): factor associated with a high prevalence of a particular gene, disease or characteristic. These factors can be country of origin, country of citizenship, race, gender, occupation, anamnesis, etc.
Data time stamp: (UTC) — Items processed: 128
The report is generated based on the settings on Property:P5642#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
Data time stamp: (UTC) — Items processed: 128
The report is generated based on the settings on Property:P5642#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
"Type gene (Q7187), disease (Q12136)" violations[edit]
Violations count: 3
- identity theft (Q471880): theft (Q2727213), fraud (Q28813)
- smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- Dercum's disease (Q96376250): Wikimedia duplicated page (Q17362920)
Types statistics[edit]
"Value type profession (Q28640), biological sex (Q290), medical history (Q188952)" violations[edit]
Violations count: 209
- Crohn's disease (Q1472): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- cancer (Q12078): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- myocardial infarction (Q12152): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- pneumonia (Q12192): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- pneumonia (Q12192): cystic fibrosis (Q178194): designated intractable/rare disease (Q42303753), class of disease (Q112193867), symptom or sign (Q112965645), autosomal recessive disease (Q10267817), lung disease (Q3392853), genetic biliary tract disease (Q55785521), genetic pancreatic disease (Q55785598), rare genetic respiratory disease (Q55785522), rare male fertility disorder with obstructive azoospermia (Q55788042), rare genetic disorder with obstructive azoospermia (Q55788066), syndrome (Q179630), disease (Q12136)
- pneumonia (Q12192): chronic obstructive pulmonary disease (Q199804): class of disease (Q112193867), obstructive lung disease (Q3508797), disease (Q12136)
- pneumonia (Q12192): asthma (Q35869): class of disease (Q112193867), bronchospasm (Q279330), disease (Q12136)
- pneumonia (Q12192): diabetes (Q12206): class of disease (Q112193867), glucose metabolism disease (Q18556224), disease (Q12136)
- pneumonia (Q12192): heart failure (Q181754): complication (Q1346149), symptom or sign (Q112965645), cardiovascular disease (Q389735), clinical sign (Q1441305), cardiovascular system symptom (Q102186826)
- stroke (Q12202): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- diabetes (Q12206): maternal smoking (Q56196009): bad habit (Q17004554), smoking (Q662860)
- carcinoma (Q33525): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- asthma (Q35869): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- asthma (Q35869): air pollution (Q131123): environmental pollution (Q13065634), pollution (Q58734), emission (Q105766508)
- major depressive disorder (Q42844): substance abuse (Q3184856): human activity (Q61788060), class of disease (Q112193867), crime (Q83267), social issue (Q1920219), psychoactive drug use (Q110207349), disease (Q12136)
- major depressive disorder (Q42844): chronic condition (Q383126): disease attributes (Q54932064), disease (Q12136), risk factor (Q1475848)
- lung cancer (Q47912): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- dementia (Q83030): arterial hypertension (Q41861): class of disease (Q112193867), symptom or sign (Q112965645), vascular disease (Q1266890), artery disease (Q18965518), clinical sign (Q1441305), hypertension (Q95566669), disease (Q12136)
- dementia (Q83030): deafness (Q12133): symptom or sign (Q112965645), sensory loss (Q2289481), hearing disorder (Q1644260), ear symptom (Q102187283), sensory disability (Q115269691)
- dementia (Q83030): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- dementia (Q83030): obesity (Q12174): health risk (Q87075524), class of disease (Q112193867), symptom or sign (Q112965645), overnutrition (Q16956975), disease (Q12136)
- dementia (Q83030): mental depression (Q4340209): class of disease (Q112193867), symptom or sign (Q112965645), mood disorder (Q188638), neurological and physiological symptom (Q99860490), disease (Q12136)
- dementia (Q83030): sedentary lifestyle (Q1349358): determinants of health (Q3706138), human behavior (Q3769299), risk factor (Q1475848)
- dementia (Q83030): diabetes (Q12206): class of disease (Q112193867), glucose metabolism disease (Q18556224), disease (Q12136)
- dementia (Q83030): social isolation (Q1778765): social phenomenon (Q602884), solitude (Q6010868), risk factor (Q1475848), human behavior (Q3769299)
- dementia (Q83030): cranial trauma (Q2920572): major trauma (Q1064904), injury (Q193078), head and neck disease (Q55789477)
- dementia (Q83030): alcohol abuse (Q7331102): class of disease (Q112193867), substance abuse (Q3184856), alcohol consumption (Q2647488), alcohol-related disorders (Q56014553)
- dementia (Q83030): air pollution (Q131123): environmental pollution (Q13065634), pollution (Q58734), emission (Q105766508)
- appendicitis (Q121041): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- breast cancer (Q128581): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- toothache (Q143925): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- anaphylaxis (Q168800): Nucynta (Q47521917): pharmaceutical product (Q28885102)
- mumps (Q176741): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- psoriasis (Q179945): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- psoriasis (Q179945): stress (Q123414): failure mode (Q100151658), biological process (Q2996394), risk factor (Q1475848)
- psoriasis (Q179945): obesity (Q12174): health risk (Q87075524), class of disease (Q112193867), symptom or sign (Q112965645), overnutrition (Q16956975), disease (Q12136)
- psoriasis (Q179945): Xerosis cutis (Q2723497): skin disease (Q949302)
- heart failure (Q181754): coronary artery disease (Q844935): class of disease (Q112193867), artery disease (Q18965518), cardiovascular disease (Q389735), disease (Q12136)
- heart failure (Q181754): diabetes (Q12206): class of disease (Q112193867), glucose metabolism disease (Q18556224), disease (Q12136)
- heart failure (Q181754): arterial hypertension (Q41861): class of disease (Q112193867), symptom or sign (Q112965645), vascular disease (Q1266890), artery disease (Q18965518), clinical sign (Q1441305), hypertension (Q95566669), disease (Q12136)
- heart failure (Q181754): overweight (Q332428): syndrome (Q179630), abnormally high value (Q63345803), symptom or sign (Q112965645), overnutrition (Q16956975)
- sepsis (Q183134): infection (Q166231): failure mode (Q100151658), physiological condition (Q7189713), adverse event (Q11516357), risk source (Q86923152), health problem (Q2057971)
- Factor V Leiden (Q185986): estrogen (Q277954): class of chemical entities with similar applications or functions (Q56256173), sex steroid (Q422812), hormone (Q11364), steroid hormone (Q422137)
- colorectal cancer (Q188874): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- colorectal cancer (Q188874): obesity (Q12174): health risk (Q87075524), class of disease (Q112193867), symptom or sign (Q112965645), overnutrition (Q16956975), disease (Q12136)
- colorectal cancer (Q188874): alcohol and cancer (Q4713253): long-term effects of alcohol consumption (Q1340700), cancer (Q12078), diet and cancer (Q4117942)
- colorectal cancer (Q188874): age of a person (Q185836): age (Q100343219), physical quantity (Q107715), duration (Q2199864)
- heart disease (Q190805): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- Tourette syndrome (Q191779): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- chronic obstructive pulmonary disease (Q199804): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- anogenital venereal wart (Q208726): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- lactose intolerance (Q219223): age of a person (Q185836): age (Q100343219), physical quantity (Q107715), duration (Q2199864)
- lactose intolerance (Q219223): ethnicity (Q5404323): property (Q937228)
- leishmaniasis (Q331283): malnutrition (Q12167): academic discipline (Q11862829), failure mode (Q100151658), nutrition disorder (Q1361144), clinical sign (Q1441305)
- leishmaniasis (Q331283): human migration (Q177626): migration (Q1800545), occurrence (Q1190554)
- leishmaniasis (Q331283): immunosuppression (Q1455316): immunotherapy (Q1427096)
- leishmaniasis (Q331283): deforestation (Q169940): process (Q3249551), resource depletion (Q3737914), human impact on the environment (Q574376)
- leishmaniasis (Q331283): urbanization (Q161078): trend (Q1514415)
- carpal tunnel syndrome (Q332293): ergonomic hazard (Q24965499): health risk (Q87075524)
- amenorrhea (Q334655): anorexia nervosa (Q131749): class of disease (Q112193867), mental disorder (Q12135), eating disorder (Q373822), disease (Q12136)
- amenorrhea (Q334655): obesity (Q12174): health risk (Q87075524), class of disease (Q112193867), symptom or sign (Q112965645), overnutrition (Q16956975), disease (Q12136)
- adenocarcinoma (Q356033): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- uveal melanoma (Q356372): nevus of Ota (Q2053690): symptom or sign (Q112965645), class of disease (Q112193867), hyperpigmentation (Q1641068), ocular melanosis (Q1392911), nevus (Q692077), conjunctival nevus (Q18553551)
- peripheral artery disease (Q378681): tobacco use disorder (Q152100): class of disease (Q112193867), non-controlled substance abuse (Q182413), smoking addiction (Q28092948), health effects of tobacco (Q465016), tobacco use (Q67171878), nicotine dependence (Q18553444), non-controlled substance abuse (Q182413)
- peripheral artery disease (Q378681): arterial hypertension (Q41861): class of disease (Q112193867), symptom or sign (Q112965645), vascular disease (Q1266890), artery disease (Q18965518), clinical sign (Q1441305), hypertension (Q95566669), disease (Q12136)
- peripheral artery disease (Q378681): diabetes (Q12206): class of disease (Q112193867), glucose metabolism disease (Q18556224), disease (Q12136)
- post-thrombotic syndrome (Q382091): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- cardiovascular disease (Q389735): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- acanthosis nigricans (Q415833): insulin resistance (Q1053470): class of disease (Q112193867), diabetes (Q12206), drug resistance (Q12147416)
- identity theft (Q471880): data breach (Q1172486): information leakage (Q2775060), security breach (Q93616941), crime (Q83267)
- hyperinsulinism (Q477390): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- Kohler's disease (Q578257): child (Q7569): demographic profile (Q5932254), population group (Q851990), human (Q5), juvenile (Q1516282)
- Kohler's disease (Q578257): boy (Q3010): child (Q7569), male human (Q84048850)
- smoking (Q662860): substance abuse (Q3184856): human activity (Q61788060), class of disease (Q112193867), crime (Q83267), social issue (Q1920219), psychoactive drug use (Q110207349), disease (Q12136)
- smoking (Q662860): mental disorder (Q12135): class of disease (Q112193867), disease (Q12136)
- smoking (Q662860): specific phobia (Q2015728): class of disease (Q112193867), phobia (Q175854), genetic disease (Q200779), genetic nervous system disorder (Q55788492), disease (Q12136)
- smoking (Q662860): anhedonia (Q545365): psychopathological symptom (Q30897648), symptom or sign (Q112965645), neurobehavioral manifestation (Q54945855)
- dermatomyositis (Q681160): maternal smoking (Q56196009): bad habit (Q17004554), smoking (Q662860)
- squamous cell carcinoma (Q681817): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- tennis elbow (Q736776): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- Babesiosis (Q797668): immunosuppression (Q1455316): immunotherapy (Q1427096)
- Babesiosis (Q797668): spleen (Q9371): organ type (Q103812529), class of anatomical entity (Q112826905), animal organ (Q24060765), lymphoid tissue (Q3529455), corticomedullary organ (Q66545290), blood forming organ (Q109173541), particular anatomical entity (Q112826975)
- coronary artery disease (Q844935): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- Peyronie's disease (Q874586): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- repetitive strain injury (Q877796): ergonomic hazard (Q24965499): health risk (Q87075524)
- liver disease (Q929737): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- purpura (Q935293): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- dentine hypersensitivity (Q948056): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- skin disease (Q949302): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- insulin resistance (Q1053470): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- tic disorder (Q1077139): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- angioedema (Q1129007): Nucynta (Q47521917): pharmaceutical product (Q28885102)
- Lewy body dementia (Q1331905): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- osteopenia (Q1367706): old age (Q191089): phase of human life (Q785260), development of the human body (Q2347178), senescence (Q2070979), age of a person (Q185836)
- osteopenia (Q1367706): alcoholism (Q15326): symptom or sign (Q112965645), alcohol abuse (Q7331102), dependence syndrome (Q16697828), substance use disorder (Q7632070)
- osteopenia (Q1367706): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- arteriosclerotic heart disease (Q1444550): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- arteriosclerotic heart disease (Q1444550): tobacco smoking (Q7212330): smoking (Q662860)
- arteriosclerotic heart disease (Q1444550): age of a person (Q185836): age (Q100343219), physical quantity (Q107715), duration (Q2199864)
- arteriosclerotic heart disease (Q1444550): sedentary lifestyle (Q1349358): determinants of health (Q3706138), human behavior (Q3769299), risk factor (Q1475848)
- arteriosclerotic heart disease (Q1444550): psychological stress (Q3500368): negative emotion (Q60539481), mental state (Q3968640), risk factor (Q1475848), stress (Q123414)
- arteriosclerotic heart disease (Q1444550): atherosclerosis (Q12252367): class of disease (Q112193867), arteriosclerotic cardiovascular disease (Q18555060), arteriosclerosis (Q184559), disease (Q12136)
- arteriosclerotic heart disease (Q1444550): autoimmune disease (Q8084905): class of disease (Q112193867), hypersensitivity (Q5958765), disease (Q12136), immune disorder (Q3843811), primary immunodeficiency disease (Q3043160)
- arteriosclerotic heart disease (Q1444550): chronic renal insufficiency (Q736715): chronic condition (Q383126), class of disease (Q112193867), kidney failure (Q476921), kidney disease (Q1054718), chronic renal disease (Q11495077), disease (Q12136)
- arteriosclerotic heart disease (Q1444550): congenital heart disease (Q939364): developmental defect during embryogenesis (Q55788864), rare disease (Q929833), class of disease (Q112193867), heart disease (Q190805), congenital disorder (Q727096), cardiovascular abnormality (Q54911848), genetic cardiac disease (Q55789068), genetic disease (Q200779), rare genetic developmental defect during embryogenesis (Q55785846), disease (Q12136)
- arteriosclerotic heart disease (Q1444550): diabetes (Q12206): class of disease (Q112193867), glucose metabolism disease (Q18556224), disease (Q12136)
- arteriosclerotic heart disease (Q1444550): hyperlipidemia (Q1079120): class of disease (Q112193867), lipid metabolism disorder (Q1476525), metabolic disease (Q2351083)
- arteriosclerotic heart disease (Q1444550): arterial hypertension (Q41861): class of disease (Q112193867), symptom or sign (Q112965645), vascular disease (Q1266890), artery disease (Q18965518), clinical sign (Q1441305), hypertension (Q95566669), disease (Q12136)
- arteriosclerotic heart disease (Q1444550): hypertriglyceridemia (Q1467339): disease (Q12136), inherited metabolic disorder (Q1758393), hyperlipidemia (Q1079120), metabolic disease (Q2351083)
- arteriosclerotic heart disease (Q1444550): HIV/AIDS (Q12199): endemic disease (Q506680), syndrome (Q179630), pandemic (Q12184), class of disease (Q112193867), symptom or sign (Q112965645), human immunodeficiency virus infectious disease (Q18556697), acquired immunodeficiency (Q12131931), sexually transmitted infection (Q12198), disease (Q12136)
- arteriosclerotic heart disease (Q1444550): metabolic syndrome (Q657193): syndrome (Q179630), medicalization (Q1134368), disease mongering (Q1228633), rare disease (Q929833), class of disease (Q112193867), abdominal obesity-metabolic syndrome (Q27164421), disease (Q12136)
- arteriosclerotic heart disease (Q1444550): obesity (Q12174): health risk (Q87075524), class of disease (Q112193867), symptom or sign (Q112965645), overnutrition (Q16956975), disease (Q12136)
- arteriosclerotic heart disease (Q1444550): sleep apnea (Q213600): class of disease (Q112193867), symptom or sign (Q112965645), sleep disorder (Q177190), apnea (Q754424), sleep-related breathing disorder (Q102221481), disease (Q12136)
- arteriosclerotic heart disease (Q1444550): insomnia (Q1869874): disease (Q12136), symptom or sign (Q112965645), sleep disorder (Q177190), sleep disturbance (Q102187069)
- carcinogenesis (Q1637543): ionizing radiation (Q186161): radiation (Q18335)
- carcinogenesis (Q1637543): pathogen (Q170065): disease causative agent (Q2826767), biological hazard (Q864360), organism (Q7239)
- carcinogenesis (Q1637543): carcinogen (Q187661): risk source (Q86923152), causes of cancer (Q18205885), substance (Q10683158), noxa (Q50379880)
- clavicle fracture (Q1746068): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- head and neck cancer (Q1783924): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- fasciitis (Q1870975): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- lung abscess (Q1877550): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- gastrointestinal system disease (Q2300099): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- pregnancy over age 50 (Q2372105): complications of pregnancy (Q2916477): disease (Q12136), complication of pregnancy, childbirth and the puerperium (Q18975815), complication (Q1346149)
- pregnancy over age 50 (Q2372105): miscarriage (Q28693): disease (Q12136), symptom or sign (Q112965645), complications of pregnancy (Q2916477), pregnancy with abortive outcome (Q96649463), reproductive system symptom (Q102186786)
- mouth disease (Q2508462): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- sinus arrhythmia (Q2583597): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- umbilical hernia (Q2737426): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- cerebrovascular disease (Q3010352): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- type 2 diabetes (Q3025883): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- neurological disorder (Q3339235): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- neurological disorder (Q3339235): maternal smoking (Q56196009): bad habit (Q17004554), smoking (Q662860)
- central retinal artery occlusion (Q3348620): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- drug overdose (Q3505252): substance abuse (Q3184856): human activity (Q61788060), class of disease (Q112193867), crime (Q83267), social issue (Q1920219), psychoactive drug use (Q110207349), disease (Q12136)
- obstructive lung disease (Q3508797): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- epithelioma (Q3542027): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- stable angina (Q3617336): hyperlipidemia (Q1079120): class of disease (Q112193867), lipid metabolism disorder (Q1476525), metabolic disease (Q2351083)
- stable angina (Q3617336): diabetes (Q12206): class of disease (Q112193867), glucose metabolism disease (Q18556224), disease (Q12136)
- stable angina (Q3617336): cigarette smoking (Q67433631): tobacco smoking (Q7212330)
- stable angina (Q3617336): hypertension (Q95566669): disease (Q12136), disease (Q12136)
- atrophic vaginitis (Q4007235): menopause (Q177708): biological process (Q2996394), women's disease (Q1451794), menstrual cycle phase (Q14908045), climacteric (Q603557), reproductive senescence (Q22299008)
- atrophic vaginitis (Q4007235): breastfeeding (Q174876): nutrition (Q2138622), infant feeding (Q50146839), lactation (Q719426)
- airway obstruction (Q4330029): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- mental depression (Q4340209): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- branch retinal artery occlusion (Q4956398): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- cortical deafness (Q5173263): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- female reproductive system disease (Q5442760): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- gastrointestinal system cancer (Q5526839): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- hypersensitivity (Q5958765): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- Chronic bee paralysis (Q6065192): varroosis (Q780805): infectious disease (Q18123741), bee disease (Q56373839)
- childhood type dermatomyositis (Q6318950): maternal smoking (Q56196009): bad habit (Q17004554), smoking (Q662860)
- no reflow phenomenon (Q7045267): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- pelvic floor dysfunction (Q7161799): maternal smoking (Q56196009): bad habit (Q17004554), smoking (Q662860)
- meningococcal meningitis (Q7386479): maternal smoking (Q56196009): bad habit (Q17004554), smoking (Q662860)
- nutritional optic neuropathy (Q7830375): nutritional deficiency disease (Q1890194): class of disease (Q112193867), nutrition disorder (Q1361144), deficiency (Q63645073)
- urinary system disease (Q7900883): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- necrotizing enterocolitis (Q10859678): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- atherosclerosis (Q12252367): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- atherosclerosis (Q12252367): binge eating (Q2303219): disordered eating (Q5282515)
- ovarian mucinous cystadenocarcinoma (Q13451619): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- lung neoplasm (Q15124212): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- opioid overdose (Q17154378): opioid use disorder (Q1639178): class of disease (Q112193867), addiction (Q12029), substance abuse (Q3184856), opioid-related disorders (Q67085655), addiction (Q12029), disease (Q12136)
- opioid overdose (Q17154378): chronic pain (Q1088113): pain (Q81938), physiological condition (Q7189713), symptom or sign (Q112965645), clinical sign (Q1441305), pain (Q81938)
- opioid overdose (Q17154378): mental distress (Q6817452): risk factor (Q1475848), distress (Q5283089)
- lower respiratory tract disease (Q18553224): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- large intestine adenocarcinoma (Q18553556): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- larynx squamous papilloma (Q18553776): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- esophageal carcinoma (Q18553999): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- acute serous otitis media (Q18554108): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- cardiovascular cancer (Q18554898): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- enamel caries (Q18555021): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- plasma protein metabolism disease (Q18555057): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- sensory peripheral neuropathy (Q18555098): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- squamous cell neoplasm (Q18555316): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- acute transudative otitis media (Q18556028): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- small intestine carcinoma (Q18556538): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- esophagus adenocarcinoma (Q18556542): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- gallbladder carcinoma (Q18556564): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- testicular germ cell tumor (Q18556865): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- superficial urinary bladder cancer (Q18557565): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- retinal artery occlusion (Q18557950): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- soft palate cancer (Q18557973): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- bowel dysfunction (Q18558220): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- neurotic disorder (Q19000444): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- peripheral vascular disease (Q26695607): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- running injury (Q30314084): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- hypotrichosis 2 (Q32140239): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- infection associated with diseases (Q42417296): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- gaming disorder (Q49000071): mental disorder (Q12135): class of disease (Q112193867), disease (Q12136)
- gingival squamous cell carcinoma (Q53678376): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- multiple pulmonary nodules (Q54972627): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- heart failure with reduced ejection fraction (Q56218018): smoking (Q662860): custom (Q251777), psychoactive drug use (Q110207349)
- Vaping-associated pulmonary injury (Q74061523): D-α-tocopherol acetate (Q364160): type of chemical entity (Q113145171), vitamin E (Q141180), chromane (Q73905244)
- Vaping-associated pulmonary injury (Q74061523): tetrahydrocannabinol (Q190067): type of chemical entity (Q113145171), cannabinoids (Q422936), menthane monoterpenoids (Q66124573)
- COVID-19 (Q84263196): arterial hypertension (Q41861): class of disease (Q112193867), symptom or sign (Q112965645), vascular disease (Q1266890), artery disease (Q18965518), clinical sign (Q1441305), hypertension (Q95566669), disease (Q12136)
- COVID-19 (Q84263196): obesity (Q12174): health risk (Q87075524), class of disease (Q112193867), symptom or sign (Q112965645), overnutrition (Q16956975), disease (Q12136)
- COVID-19 (Q84263196): diabetes (Q12206): class of disease (Q112193867), glucose metabolism disease (Q18556224), disease (Q12136)
- COVID-19 (Q84263196): coronary artery disease (Q844935): class of disease (Q112193867), artery disease (Q18965518), cardiovascular disease (Q389735), disease (Q12136)
- COVID-19 (Q84263196): immunodeficiency (Q641307): immune disorder (Q3843811)
- COVID-19 (Q84263196): hypercholesterolemia (Q762713): class of disease (Q112193867), hyperlipidemia (Q1079120)
- COVID-19 (Q84263196): chronic obstructive pulmonary disease (Q199804): class of disease (Q112193867), obstructive lung disease (Q3508797), disease (Q12136)
- COVID-19 (Q84263196): autoimmune disease (Q8084905): class of disease (Q112193867), hypersensitivity (Q5958765), disease (Q12136), immune disorder (Q3843811), primary immunodeficiency disease (Q3043160)
- COVID-19 (Q84263196): hyperglycemia (Q271993): class of disease (Q112193867), abnormally high value (Q63345803), glucose metabolism disease (Q18556224), disease (Q12136)
- COVID-19 (Q84263196): status asthmaticus (Q826759): class of disease (Q112193867), asthma (Q35869), acute asthma (Q102293791), disease (Q12136)
- COVID-19 (Q84263196): tobacco smoking (Q7212330): smoking (Q662860)
- COVID-19 (Q84263196): asthma (Q35869): class of disease (Q112193867), bronchospasm (Q279330), disease (Q12136)
- Dercum's disease (Q96376250): obesity (Q12174): health risk (Q87075524), class of disease (Q112193867), symptom or sign (Q112965645), overnutrition (Q16956975), disease (Q12136)
- feline obesity (Q116167729): sedentism (Q1141745): lifestyle (Q32090)
- feline obesity (Q116167729): genetic predisposition (Q784237): risk context (Q94704927), genetic characteristic (Q42138532), genetic disease (Q200779), disease susceptibility (Q65534164)
- feline obesity (Q116167729): food (Q2095): disposable product (Q1194058)